Description
The latest Good Publication Practice (GPP 2022) guidelines reframes and expands many of the recommendations in previous guidelines with important implications for publishing industry-funded biomedical research in Asia-Pacific (APAC). However, applying GPP 2022 in APAC can be challenging due to several factors unique to this region.
For example, patient involvement in publications, while gaining traction in APAC, is still uncommon due to political, cultural, and compliance considerations. Industry sponsors in the region may also need to navigate situations where vendor staff engaged
to support study execution and publication development may medical writers qualify for authorship in a publication, but not be paid for activities related to authorship or publication development. Although publication professionals in the region should operate with a high degree of trust, they should remain alert to signals suggesting unethical publication practices and have clear policies on how to investigate and respond to such matters.
This webinar will discuss case studies that highlight both successful practices and challenges faced in applying GPP 2022 in APAC, focusing on patient engagement in publications, third-party (e.g., CRO/agency) authorship, and ethics in publication practice.
Learning objectives, throughout this webinar, attendees will:
- Learn to identify practical approaches for navigating the publication landscape in APAC, based on real-world experience shared through a series of case study discussion
- Enhance their understanding of GPP 2022 as well as its implementation and associated challenges in the APAC context, through an in-depth panel discussion
Approved for 1.0 CMPP credit